Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Minxing,Shi

第一单位： Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

作者： Minxing,Shi ^[1] ; Wencheng,Zhao ^[1] ; Fei,Zhou ^[1] ; Hao,Chen ^[2] ; Liang,Tang ^[3] ; Bo,Su ^[3] ; Jie,Zhang ^[1]

作者单位： Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. ^[1] Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. ^[2] Central Laboratory, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. ^[3]

关键词 Pulmonary large cell neuroendocrine carcinoma (pulmonary LCNEC)immunotherapy inflammatory biomarkers neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)

DOI 10.21037/tlcr.2020.01.17

PMID 32206552

发布时间 2022-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Translational lung cancer research

2020年9卷1期

45-54页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma.

Translational lung cancer research

相似文献

Translational lung cancer research

相关期刊

检索历史清除